Laying the foundation for Real-world evidence studies: a case study from Newfoundland and Labrador.
Int J Popul Data Sci
; 7(1): 1690, 2022.
Article
em En
| MEDLINE
| ID: mdl-37650031
ABSTRACT
The Janssen and Newfoundland and Labrador Health Innovation Partnership (JANL-HIP) was established to carry out Real-World Evidence (RWE) projects to generate evidence about disease pathways, healthcare delivery, the effects of clinical interventions. Doing so will support and influence clinical decision-making in Newfoundland and Labrador (NL). This case study describes the foundational elements necessary for a real-world evidence generation project in NL and may provide learning for the effective execution of real-world studies in other jurisdictions. It uses an ongoing project in psoriatic disease in NL to illustrate the partnership and the benefits of RWE studies. Ultimately, the JANL-HIP RWE project aims to inform decisions that will drive improvements in health outcomes, system delivery, and policy mutually beneficial to health ecosystem stakeholders.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Ecossistema
/
Tomada de Decisão Clínica
Tipo de estudo:
Prognostic_studies
Limite:
Humans
País/Região como assunto:
America do norte
Idioma:
En
Revista:
Int J Popul Data Sci
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Canadá